Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial-Reference-Cited by-同舟云学术

Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial

Published:2020-02-25 Issue:5 Volume:98 Page:306-314
ISSN:0042-9686
Container-title:Bulletin of the World Health Organization
language:
Short-container-title:Bull. World Health Organ.

Author:

Madan Jason J¹,Rosu Laura²,Tefera Mamo Girma³,van Rensburg Craig⁴,Evans Denise⁴,Langley Ivor²,Tomeny Ewan M²,Nunn Andrew⁵,Phillips Patrick PJ⁶,Rusen I D⁷,Squire S Bertel²,

Affiliation:

1. Warwick Medical School, University of Warwick, Coventry, England.

2. Centre for Applied Health Research and Delivery, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England.

3. Department of Business Management, Addis Ababa Science & Technology University, Addis Ababa, Ethiopia.

4. Health Economics and Epidemiology Research Office, University of Witwatersrand, Johannesburg, South Africa.

5. Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, London, England.

6. Department of Medicine, University of California San Francisco, San Francisco, United States of America (USA).

7. Division of Research and Development, Vital Strategies, New York, USA.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference27 articles.

1. Guidelines for the programmatic management of drug-resistant tuberculosis – 2011 update. Geneva: World Health Organization; 2011. Available from: http://apps.who.int/iris/bitstream/handle/10665/44597/9789241501583_eng.pdf?sequence=1 [cited 2018 Sep 1].

2. Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa.;Schnippel;Trop Med Int Health,2013

3. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?;Pooran;PLoS One,2013

4. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.;Cox;Trop Med Int Health,2015

5. Costs to health services and the patient of treating tuberculosis: a systematic literature review.;Laurence;Pharmacoeconomics,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience;The Lancet Infectious Diseases;2024-09

2. A systematic review of economic evaluations of pharmacological treatments for active tuberculosis;Frontiers in Public Health;2024-04-16

3. Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis;BMC Public Health;2024-01-22

4. An Analysis of the Accounting Costs Associated with 20-Month DR TB Regimens in Maputo City, Mozambique;Journal of Tuberculosis Research;2024

5. Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa;South African Medical Journal;2023-11-06